Terms: = Liver cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Staging
2133 results:
1. Treatment and prognosis study of spontaneous rupture hemorrhage in hepatocellular carcinoma: Recommendations for adding the A1 stage to the BCLC staging system.
Ni Q; Jia H; Zhang Y; Lu J; Chang H
Cancer Med; 2024 May; 13(10):e6952. PubMed ID: 38752672
[TBL] [Abstract] [Full Text] [Related]
2. DGPRI, a new liver fibrosis assessment index, predicts recurrence of AFP-negative hepatocellular carcinoma after hepatic resection: a single-center retrospective study.
Zhang B; Xue J; Xu B; Chang J; Li X; Huang Z; Zhao H; Cai J
Sci Rep; 2024 May; 14(1):10726. PubMed ID: 38730095
[TBL] [Abstract] [Full Text] [Related]
3. [Study on mechanism of icariin-induced ferroptosis in HepG2 hepatoma carcinoma cells through PPARG/FABP4/GPX4 pathway].
Li L; Zeng PH; Yang RY; Deng Y; He ZM; Xia X; Zhu DY; Peng QH
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1295-1309. PubMed ID: 38621977
[TBL] [Abstract] [Full Text] [Related]
4. Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
Ohama H; Hiraoka A; Tada T; Hirooka M; Kariyama K; Hatanaka T; Tani J; Takaguchi K; Atsukawa M; Itobayashi E; Nishimura T; Tsuji K; Tajiri K; Ishikawa T; Yasuda S; Toyoda H; Fukunishi S; Ogawa C; Kakizaki S; Shimada N; Naganuma A; Kawata K; Kosaka H; Kuroda H; Matono T; Yata Y; Ochi H; Tada F; Nouso K; Morishita A; Itokawa N; Okubo T; Arai T; Tsutsui A; Nagano T; Yokohama K; Nishikawa H; Imai M; Koizumi Y; Nakamura S; Iijima H; Kaibori M; Hiasa Y; Kumada T;
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2042. PubMed ID: 38577725
[TBL] [Abstract] [Full Text] [Related]
5. Patient metabolic profile defined by liver and muscle
Vitiello GA; Jayaprakasam VS; Tang LH; Schattner MA; Janjigian YY; Ku GY; Maron SB; Schoder H; Larson SM; Gönen M; Datta J; Coit DG; Brennan MF; Strong VE
Gastric Cancer; 2024 May; 27(3):548-557. PubMed ID: 38436762
[TBL] [Abstract] [Full Text] [Related]
6. HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study.
Attallah KA; Albannan MS; Farid K; Rizk SM; Fathy N
Technol Cancer Res Treat; 2024; 23():15330338241234790. PubMed ID: 38436112
[No Abstract] [Full Text] [Related]
7. [The impact of modified T3 sub-staging on the prognosis of gallbladder cancer patients].
Chen C; Zhang D; Li Q; Lei JJ; Geng ZM
Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):302-308. PubMed ID: 38432671
[No Abstract] [Full Text] [Related]
8. Integrating Navigation-Assisted Ablation in the Locoregional Treatment of Hepatocellular Carcinoma.
Iwai Y; Agala CB; Gerber DA
JAMA Netw Open; 2024 Feb; 7(2):e240694. PubMed ID: 38421644
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of survival benefit and safety between surgery following conversion therapy versus surgery alone in patients with surgically resectable hepatocellular carcinoma at CNLC IIb/IIIa stage: a propensity score matching study.
Ma Z; Xiao Z; Yin P; Wen K; Wang W; Yan Y; Lin Z; Li Z; Wang H; Zhang J; Mao K
Int J Surg; 2024 May; 110(5):2910-2921. PubMed ID: 38353702
[TBL] [Abstract] [Full Text] [Related]
10. Split-bolus single-phase versus single-bolus split-phase CT acquisition protocols for staging in patients with testicular cancer: A retrospective study.
O'Regan PW; Dewhurst C; O'Mahony AT; O'Regan C; O'Leary V; O'Connor G; Ryan D; Maher MM; Young R
Radiography (Lond); 2024 Mar; 30(2):628-633. PubMed ID: 38330895
[TBL] [Abstract] [Full Text] [Related]
11. Preoperative predictors for non-resectability in perihilar cholangiocarcinoma.
Otto CC; Mantas A; Heij LR; Heise D; Dewulf M; Lang SA; Ulmer TF; Dahl E; Bruners P; Neumann UP; Bednarsch J
World J Surg Oncol; 2024 Feb; 22(1):48. PubMed ID: 38326854
[TBL] [Abstract] [Full Text] [Related]
12. [Analysis of strong invasive clinical features and poor prognosis in macrotrabecular-massive hepatocellular carcinoma].
Shan YY; Wang CN; Mao SQ; Yu X; Sun JN; Lu CD
Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1318-1325. PubMed ID: 38253077
[No Abstract] [Full Text] [Related]
13. Diagnostic yield of contrast-enhanced abdominal staging CT in patients with initially diagnosed breast cancer.
Jeong B; Lee YW; Lee SB; Kim J; Chung IY; Kim HJ; Ko BS; Lee JW; Son BH; Gwark S; Shin HJ; Yoo TK; Choi SH
Eur J Radiol; 2024 Feb; 171():111295. PubMed ID: 38241854
[TBL] [Abstract] [Full Text] [Related]
14. [Study on the comparison of postoperative liver injury caused by hepatic arterial perfusion chemotherapy combined with targeted immunotherapy with hepatic arterial chemoembolization combined with targeted immunotherapy for intermediate-and advanced-stage liver cancer].
Li R; Li WL; Yuan GS; Pang HJ; Li Q; Hu XY; Guo YB; Chen JZ; Zang MY
Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1163-1168. PubMed ID: 38238949
[No Abstract] [Full Text] [Related]
15. Development and validation of web-based nomograms for predicting survival status in patients with intrahepatic cholangiocarcinoma depending on the surgical status: a SEER database analysis.
Liu YG; Jiang ST; Zhang JW; Zhang L; Zhao HT; Sang XT; Lu X; Xu YY
Sci Rep; 2024 Jan; 14(1):1568. PubMed ID: 38238494
[TBL] [Abstract] [Full Text] [Related]
16. Development and validation of prealbumin-bilirubin score (preALBI score) for predicting long-term survival after hepatectomy for hepatocellular carcinoma: A multicenter analysis versus ALBI score.
Li C; Wang MD; Sun XD; Diao YK; Yao LQ; Wang H; Liang YJ; Zhou YH; Gu WM; Chen TH; Chen Z; Gu LH; Shen F; Lv GY; Yang T; Huang DS
Am J Surg; 2024 Jun; 232():87-94. PubMed ID: 38238192
[TBL] [Abstract] [Full Text] [Related]
17. Treatment strategy for successful conversion surgery in clinical stage IVB gastric cancer.
Hojo Y; Ishida Y; Tomita T; Kurahashi Y; Nakamura T; Kitayama Y; Nakao E; Kohno S; Murakami M; Takeuchi J; Takagawa T; Hirota S; Shinohara H
Eur J Surg Oncol; 2024 Feb; 50(2):107314. PubMed ID: 38101115
[TBL] [Abstract] [Full Text] [Related]
18. Clinical characteristics and prognosis of primary small cell carcinoma of the breast: a propensity score-matched, population-based study.
Yin L; Yin AH; Pu CC
BMJ Open; 2023 Dec; 13(12):e073841. PubMed ID: 38097248
[TBL] [Abstract] [Full Text] [Related]
19. Improving prognostication in patients with hepatocellular carcinoma undergoing loco-regional therapy using pre- and post-locoregional therapy scores.
Thandassery RB; Lavender CA; Perisetti A; Beheshti M
Abdom Radiol (NY); 2024 Feb; 49(2):631-641. PubMed ID: 38071274
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients.
Lin KY; Chen QJ; Tang SC; Lin ZW; Zhang JX; Zheng SM; Li YT; Wang XM; Lu Q; Fu J; Guo LB; Zheng LF; You PH; Wu MM; Lin KC; Zhou WP; Yang T; Zeng YY
BMC Cancer; 2023 Dec; 23(1):1190. PubMed ID: 38053048
[TBL] [Abstract] [Full Text] [Related]
[Next]
